
Biologic drug substance CDMO services


Information
Main Categories
APIs (Active Pharmaceutical Ingredients)BiopharmaceuticalsContract Services - Analytical & Lab ServicesCustom ManufacturingFinished Dosage FormsPharmaceutical Machinery & TechnologyPharmaceutical Packaging
All Categories
Analytical DevelopmentAnalytical MethodsAntibodiesAPIs (Active Pharmaceutical Ingredients)Aseptic Contract ManufacturingAuto-injectorBiomanufacturingBiopharmaceuticalsBiopharmaceuticals (general category)Bioreactors & FermentationBiosimilarsCapacity challengesCHO and cell linesChromatographyClinical Trials Phase I to IVCMCContract ManufacturingContract PackagingContract ServicesContract Services - Analytical & Lab ServicesCool ChainCustom ManufacturingDownstreamFilling/ Fill Finish & packagingFinished Dosage FormsFormulation developmentInjectable systems and componentsInjectablesLogistics and DistributionLyophilisationMethod DevelopmentMethod ValidationMonoclonal AntibodiesParenteralsPen injectorsPharmaceutical Machinery & TechnologyPharmaceutical PackagingPlatform technologiesPrefillable syringeProcess validationProduct CharacterizationQuality controlQuality Control TestingRegulatory AffairsRegulatory consulting servicesStability TestingSterile Injectables ManufacturingSterilizationTech transfer and Scale upToxicology / VirologyUpstreamViral Clearance
Distribution areas
OceaniaNorth America (USA, Canada)Middle East Region (e.g. UAE)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)
Supplied from
United States
